DK0841392T3 - Svækket levende Neospora vaccine - Google Patents

Svækket levende Neospora vaccine

Info

Publication number
DK0841392T3
DK0841392T3 DK97308133T DK97308133T DK0841392T3 DK 0841392 T3 DK0841392 T3 DK 0841392T3 DK 97308133 T DK97308133 T DK 97308133T DK 97308133 T DK97308133 T DK 97308133T DK 0841392 T3 DK0841392 T3 DK 0841392T3
Authority
DK
Denmark
Prior art keywords
attenuated live
live neospora
neospora vaccine
vaccine
attenuated
Prior art date
Application number
DK97308133T
Other languages
English (en)
Inventor
David Brake
Byron Blagburn
David Lindsay
Original Assignee
Pfizer
Univ Auburn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21858396&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0841392(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer, Univ Auburn filed Critical Pfizer
Application granted granted Critical
Publication of DK0841392T3 publication Critical patent/DK0841392T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97308133T 1996-11-12 1997-10-14 Svækket levende Neospora vaccine DK0841392T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3124896P 1996-11-12 1996-11-12
EP97308133A EP0841392B1 (en) 1996-11-12 1997-10-14 Attenuated live neospora vaccine

Publications (1)

Publication Number Publication Date
DK0841392T3 true DK0841392T3 (da) 2004-11-22

Family

ID=21858396

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97308133T DK0841392T3 (da) 1996-11-12 1997-10-14 Svækket levende Neospora vaccine

Country Status (16)

Country Link
US (3) US6656479B2 (da)
EP (1) EP0841392B1 (da)
JP (2) JP3690709B2 (da)
CN (2) CN1226406C (da)
AR (2) AR010583A1 (da)
AT (1) ATE271122T1 (da)
AU (1) AU733076B2 (da)
BR (1) BR9705473A (da)
CA (1) CA2220588C (da)
DE (1) DE69729839T2 (da)
DK (1) DK0841392T3 (da)
ES (1) ES2224210T3 (da)
NZ (1) NZ329095A (da)
PT (1) PT841392E (da)
TW (1) TW557214B (da)
ZA (1) ZA9710130B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
BR9803232A (pt) * 1997-08-26 2000-01-11 Pfizer Prod Inc Vaicna de neospora.
WO1999020303A1 (en) 1997-10-20 1999-04-29 Bayer Corporation Neospora vaccines
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
AUPQ905600A0 (en) * 2000-07-28 2000-08-24 Insearch Limited Parasites
CN1639574A (zh) * 2001-10-31 2005-07-13 辉瑞产品公司 新孢虫的血清学检测
FR2836924B1 (fr) * 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
CA2531565C (en) 2003-07-22 2014-02-11 Vivalis Production of poxviruses with adherent or non adherent avian cell lines
SG149058A1 (en) * 2003-12-19 2009-01-29 Seattle Biomedical Res Inst Live genetically attenuated malaria vaccine
US7722860B2 (en) * 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
ES2319242B1 (es) 2005-12-23 2009-12-01 Laboratorios Hipra, S.A. Aislado avirulento de neospora canimum y sus usos.
NZ574678A (en) 2006-08-09 2012-03-30 Vivalis Method of production of transgenic avian using embryonic stem cells
EP1985305A1 (en) 2007-04-24 2008-10-29 Vivalis Duck embryonic derived stem cell lines for the production of viral vaccines
EP1995309A1 (en) * 2007-05-21 2008-11-26 Vivalis Recombinant protein production in avian EBx® cells
ES2326770B1 (es) 2007-07-13 2010-07-26 Universidad Complutense De Madrid Uso de un nuevo aislado de neospora caninum para el desarrollo de pruebas de diagnostico y para la fabricacion de productos para el tratamiento y prevencion de la infenccion causada por neospora.
FR2994193B1 (fr) * 2012-08-02 2016-05-20 Vitamfero Souches mutantes de neospora et leurs utilisations
AU2016347636B2 (en) 2015-10-28 2021-02-18 Universidad Complutense De Madrid Neospora vaccine composition
BR112019006900A2 (pt) 2016-10-05 2019-07-02 Zoetis Services Llc métodos de liofilização que proporcionam protozoários desidratados estáveis para o uso como potentes vacinas vivas
JP2021525517A (ja) 2018-05-30 2021-09-27 インスティテュート・フォー・リサーチ・イン・バイオメディシンＩｎｓｔｉｔｕｔｅ Ｆｏｒ Ｒｅｓｅａｒｃｈ Ｉｎ Ｂｉｏｍｅｄｉｃｉｎｅ 内在性活性化誘導シチジンデアミナーゼを利用することによるｂリンパ球のエンジニアリング
CN111187721A (zh) * 2020-01-17 2020-05-22 中国农业大学 grx 5基因缺失的新孢子虫弱毒虫株及其构建方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643718A (en) * 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5976553A (en) 1993-11-04 1999-11-02 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US6716423B1 (en) * 1994-03-21 2004-04-06 The Regents Of The University Of California Recombinant neospora antigens and their uses
US5889166A (en) * 1996-05-10 1999-03-30 The Regents Of The University Of California Recombinant neospora antigens and their uses
US5707617A (en) 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
WO1997017082A1 (en) * 1995-11-09 1997-05-15 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
PT841392E (pt) * 1996-11-12 2004-11-30 Univ Auburn Vacina viva atenuada de neospora
US6071737A (en) 1998-03-16 2000-06-06 The Regents Of The University Of California Equine Neospora isolate and its uses

Also Published As

Publication number Publication date
DE69729839D1 (de) 2004-08-19
CN1190127A (zh) 1998-08-12
PT841392E (pt) 2004-11-30
TW557214B (en) 2003-10-11
AU733076B2 (en) 2001-05-03
JP3935180B2 (ja) 2007-06-20
EP0841392B1 (en) 2004-07-14
ATE271122T1 (de) 2004-07-15
JP3690709B2 (ja) 2005-08-31
US6994861B2 (en) 2006-02-07
BR9705473A (pt) 1999-04-06
EP0841392A2 (en) 1998-05-13
ZA9710130B (en) 1999-06-10
US20060073157A1 (en) 2006-04-06
AR053286A2 (es) 2007-04-25
JP2005230018A (ja) 2005-09-02
DE69729839T2 (de) 2005-07-21
US20040062772A1 (en) 2004-04-01
US20020044952A1 (en) 2002-04-18
ES2224210T3 (es) 2005-03-01
JPH10167983A (ja) 1998-06-23
CA2220588C (en) 2008-07-22
US6656479B2 (en) 2003-12-02
CN1226406C (zh) 2005-11-09
CA2220588A1 (en) 1998-05-12
AR010583A1 (es) 2000-06-28
AU4520397A (en) 1998-05-14
NZ329095A (en) 1998-03-25
EP0841392A3 (en) 1999-03-24
MX9708701A (es) 1998-09-30
CN1572322A (zh) 2005-02-02

Similar Documents

Publication Publication Date Title
DE69729839D1 (de) Attenuierter lebender Neospora Impfstoff
NO991524D0 (no) Vaksiner
FI20095582A (fi) Röntgenkuvauslaitteisto
ID21031A (id) Kornea buatan
GB9711964D0 (en) Live attenuated vaccines
DE59708196D1 (de) Rastschaltwerk
FI974420A (fi) Röntgenkuvauslaitteisto
ID17860A (id) Komposisi vaksin
DE59707666D1 (de) Gezogenes Gerät
DE69733812D1 (de) Heizkessel
DK0956042T3 (da) Mykosevaccine
DE59712036D1 (de) Computertomograph
ATE277631T1 (de) Neospora impstoff
NO971648L (no) Rör
NO303371B1 (no) Oppdrettsmerd
DE59609687D1 (de) Faltrollostange
KR960008272U (ko) 아파트 입상관 슬리브
KR960011347U (ko) 아파트식 분묘
KR960036206U (ko) 구두주걱
KR980000229U (ko) 주머니가 형성된 각반
KR970054891U (ko) 트랩
KR970048741U (ko) 쥐 포획기
KR970008136U (ko) 관
KR970056527U (ko) 숨쉬는 팬티스타킹
KR980004868U (ko) 회초리